FTI
CRL icon

Fiduciary Trust International’s Charles River Laboratories CRL Stock Holding History

Fiduciary Trust International’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$959K Hold
5,500
– – 0.16% 77
2020
Q1 		$694K Hold
5,500
– – 0.13% 94
2019
Q4 		$840K Buy
+5,500
New +$762K 0.13% 91

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Fiduciary Trust International's CRL Position: Q2 2020 in Review

Fiduciary Trust International held its Charles River Laboratories (CRL) position steady in Q2 2020 at 5,500 shares worth $959K. The position accounts for 0.16% of the portfolio, ranked #77.

Fiduciary Trust International first reported a position in CRL in Q4 2019 and has held it in 3 quarters since. 466 funds tracked by Wall St. Rank hold CRL as of Q2 2020.

  • Fiduciary Trust International held 5,500 shares of Charles River Laboratories worth $959K as of Q2 2020.
  • Fiduciary Trust International left its Charles River Laboratories share count unchanged in Q2 2020.
  • Charles River Laboratories made up 0.16% of Fiduciary Trust International's portfolio in Q2 2020, its #77 holding.
  • Fiduciary Trust International first reported a position in Charles River Laboratories in Q4 2019 and has held it in 3 quarters since.
  • 466 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2020.

Based on Fiduciary Trust International's 13F filing for Q2 2020, filed 11 Aug 2020.